Clinical Trials Directory

Trials / Terminated

TerminatedNCT00444808

Analgesic Effect of Intranasal Calcitonin on Patients With Fractured Ribs

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Université de Montréal · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study, which will be conducted at the emergency room of the Sacré-Cœur hospital, requires the recruitment of 60 subjects and involves some telephone follow-up. Calcitonin administered as an intranasal spray is already used to relieve pain caused by broken vertebrae and we seek to determine if it can be as efficient in the case of pain caused by broken ribs.This study aims at testing the hypothesis that subjects suffering from the accidental fracture of one or more ribs will get relief through the intranasal spraying of calcitonin and/or will use less opiate medication for pain relief (a combination of oxycodone chlorhydrate and acetaminophen called Percocet®).

Conditions

Interventions

TypeNameDescription
DRUGIntranasal calcitonin

Timeline

Start date
2007-02-01
Completion
2008-01-01
First posted
2007-03-08
Last updated
2008-06-04

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00444808. Inclusion in this directory is not an endorsement.